Synthetic biomarkers: a twenty-first century path to early cancer detection | Nature Reviews Cancer
Biomarkers in drug discovery and development
Prognostic and predictive biomarkers in Renal Cell Carcinoma. | Download Table
Frontiers | The Identification of Immunological Biomarkers in Kidney Cancers
Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature - ScienceDirect
Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors - eBioMedicine
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics | Communications Biology
How are biomarkers used to treat cancer? | MD Anderson Cancer Center
An Immune Atlas of Clear Cell Renal Cell Carcinoma - ScienceDirect
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review: Molecular Therapy - Nucleic Acids
Diseases | Free Full-Text | Proficient Novel Biomarkers Guide Early Detection of Acute Kidney Injury: A Review
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
What is a Biomarker? | Lippincott NursingCenter
Cabozantinib Slows Progression of Rare Kidney Cancer - NCI
A renal cell carcinoma tumorgraft platform to advance precision medicine - ScienceDirect
Frontiers | Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect
Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach - eBioMedicine
Self-Referenced Synthetic Urinary Biomarker for Quantitative Monitoring of Cancer Development | Journal of the American Chemical Society
Frontiers | Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy
Comprehensive molecular characterization of clear cell renal cell carcinoma | Nature
Biomarkers in renal cell carcinoma: Are we there yet? - ScienceDirect
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
